» Articles » PMID: 34020980

VALUE Study: a Protocol for a Qualitative Semi-structured Interview Study of IVF Add-ons Use by Patients, Clinicians and Embryologists in the UK and Australia

Overview
Journal BMJ Open
Specialty General Medicine
Date 2021 May 22
PMID 34020980
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: For couples undergoing assisted reproduction, a plethora of adjuncts are available; these are known as 'add-ons'. Most add-ons are not supported by good quality randomised trial evidence of efficacy, with some proven to be ineffective. However, estimates suggest that over 70% of fertility clinics provide at least one add-on, often at extra cost to the patient. This study has three aims. First, to undertake a survey of in vitro fertilisation (IVF) clinics in the UK to ascertain which add-ons are being offered and at what cost. Second, to undertake qualitative semi-structured interviews of patients, clinicians and embryologists, to explore their opinions and beliefs surrounding add-ons. Third, to review the interpretation of the Human Fertilisation and Embryology Authority traffic light system, to better understand the information required by IVF patients, clinicians and embryologists when making decisions about add-ons.

Methods And Analysis: All UK IVF clinics will be contacted by email and invited to complete an online survey. The survey will ask them which add-ons they offer, at what cost per cycle and how information is shared with patients. Semi-structured interviews will be conducted in the UK and Australia with three groups of participants: (i) fertility patients; (ii) clinicians and (iii) embryologists. Participants for the interviews will be recruited via social media channels, website adverts, email and snowball sampling. Up to 20 participants will be recruited for each group in each country. Following an online consent process, interviews will be conducted via video-conferencing software, transcribed verbatim and data subjected to inductive thematic analysis.

Ethics And Dissemination: Ethical approval has been granted by the Universities of Sheffield, Bath Spa and Melbourne. Findings will be published in a peer-reviewed journal and disseminated to regulatory bodies in the UK and Australia. A lay summary of findings will be shared via Fertility Network, UK.

Citing Articles

Patient and professional perspectives about using in vitro fertilisation add-ons in the UK and Australia: a qualitative study.

Armstrong S, Vaughan E, Lensen S, Caughey L, Farquhar C, Pacey A BMJ Open. 2023; 13(7):e069146.

PMID: 37495387 PMC: 10373702. DOI: 10.1136/bmjopen-2022-069146.


"It all depends on why it's red": qualitative interviews exploring patient and professional views of a traffic light system for IVF add-ons.

Lensen S, Armstrong S, Vaughan E, Caughey L, Peate M, Farquhar C Reprod Fertil. 2023; .

PMID: 37140974 PMC: 10305467. DOI: 10.1530/RAF-22-0136.

References
1.
Greenhalgh T, Hinton L, Finlay T, Macfarlane A, Fahy N, Clyde B . Frameworks for supporting patient and public involvement in research: Systematic review and co-design pilot. Health Expect. 2019; 22(4):785-801. PMC: 6737756. DOI: 10.1111/hex.12888. View

2.
Heneghan C, Spencer E, Bobrovitz N, Collins D, Nunan D, Pluddemann A . Lack of evidence for interventions offered in UK fertility centres. BMJ. 2016; 355:i6295. DOI: 10.1136/bmj.i6295. View

3.
Zemyarska M . Is it ethical to provide IVF add-ons when there is no evidence of a benefit if the patient requests it?. J Med Ethics. 2019; 45(5):346-350. DOI: 10.1136/medethics-2018-104983. View

4.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M . Developing and evaluating complex interventions: the new Medical Research Council guidance. Int J Nurs Stud. 2012; 50(5):587-92. DOI: 10.1016/j.ijnurstu.2012.09.010. View

5.
Macklon N, Ahuja K, Fauser B . Building an evidence base for IVF 'add-ons'. Reprod Biomed Online. 2019; 38(6):853-856. DOI: 10.1016/j.rbmo.2019.04.005. View